Stryker Corp., of Kalamazoo, Mich., reported that the U.S. FDA has given the green light to the Neuroform Atlas stent system, which previously was approved under a humanitarian device exemption (HDE). (See BioWorld MedTech, Nov. 10, 2017.) It is intended for wide-neck, intracranial aneurysms in conjunction with embolic detachable coils.